TITLE

Demystifying Stem Cells

AUTHOR(S)
Oz, Mehmet C.; Mangi, Abeel A.
PUB. DATE
January 2005
SOURCE
Medical Update;2005, Vol. 30 Issue 7, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Focuses on the effects of the decision of the U.S. to limit the embryonic stem cell research on medical community. Decision of several U.S. scientists to perform their study in privately-funded laboratories; Approaches adopted by several countries to regulate the research on human embryonic stem cells; Impact of limiting the research on the country; Need for the U.S. President to allow federal funding for stem cell-related research. INSET: Stem Cell Glossary.
ACCESSION #
16247017

 

Related Articles

  • Bush's bind on stem-cell research. Schorr, Daniel // Christian Science Monitor;8/3/2001, Vol. 93 Issue 175, p11 

    Discusses the issue of whether stem-cell research in the United States should receive federal funding, and the decision which President George W. Bush must make regarding the issue, in light of his visit with Pope John Paul II.

  • Who will profit from stem cell research?  // Westchester County Business Journal;8/19/2002, Vol. 41 Issue 33, p15 

    Discusses the monopoly of laboratories established by the U.S. government as suppliers of embryonic stem cells for scientists seeking federal funding. Regulatory powers of the National Institutes of Health over the laboratories; Issues surrounding the patenting of pluripotent cell lines;...

  • Bush policy: Attention turns to existing human ES cells. Cimons, Marlene // Nature Medicine;Sep2001, Vol. 7 Issue 9, p981 

    Reports on the announcement of a policy on federal funding for human embryonic stem (ES) cell research in the United States by President George W. Bush in August 2001. Overview of the policy; Controversy related to the ES cells research; Impact of political uncertainty in the nation on research.

  • Dr. Frankenstein's charter. Grace, Kevin Michael // Report / Newsmagazine (National Edition);4/1/2002, Vol. 29 Issue 7, p10 

    Focuses on experimentation on human embryos in Canada. Outlook for legislation to regulate reproductive technology such as cloning, stem-cell research, and fetal-tissue research; Role of the Canadian Institutes for Health Research (CIHR) in setting guidelines for federally funded research; View...

  • Dr. Frankenstein's charter. Grace, Kevin Michael // Report / Newsmagazine (BC Edition);4/1/2002, Vol. 29 Issue 7, p10 

    Focuses on experimentation on human embryos in Canada. Outlook for legislation to regulate reproductive technology such as cloning, stem-cell research, and fetal-tissue research; Role of the Canadian Institutes for Health Research (CIHR) in setting guidelines for federally funded research; View...

  • Dr. Frankenstein's charter. Grace, Kevin Michael // Report / Newsmagazine (Alberta Edition);4/1/2002, Vol. 29 Issue 7, p10 

    Focuses on experimentation on human embryos in Canada. Outlook for legislation to regulate reproductive technology such as cloning, stem-cell research, and fetal-tissue research; Role of the Canadian Institutes for Health Research (CIHR) in setting guidelines for federally funded research; View...

  • Cellular Divide. Begley, Sharon; Murr, Andrew; Check, Erika; Rogers, Adam // Newsweek (Pacific Edition);7/16/2001 (Pacific Edition), Vol. 138 Issue 3, p28 

    Discusses the controversy over research on stem cells taken from human embryos in the United States. Mention that the embryos are often left over at in vitro fertilization centers; Topic of the moral and ethical issues surrounding the research; Question of whether President George W. Bush will...

  • NEXT BATTLE IN THE STEM-CELL WAR. Munro, Neil // National Journal;9/1/2001, Vol. 33 Issue 35, p2676 

    Focuses on the proposed federal funding for embryonic stem cell research in the United States. Views of Tommy G. Thompson, Health and Human Services Secretary, on research funding; Opposition on the proposed research funds; Amount of federal fund proposed for the research; Issues surrounding...

  • STEP FOR STEM CELLS. Park, Alice // Time;8/16/2010, Vol. 176 Issue 7, p15 

    The article reports that a human trial of an embryonic stem cell treatment for spinal cord injury has been approved by the U.S. Food and Drug Administration (FDA).

Share

Other Topics